celecoxib and alpha-aminopyridine

celecoxib has been researched along with alpha-aminopyridine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Brueggemann, LI; Byron, KL; Cribbs, LL; Dowell, ML; Kakad, PP; Love, RB; Solway, J	1
Arendt-Nielsen, L; Harris, S; Hummel, M; Kapil, R; Knappenberger, T; Kyle, D; O'Keefe, S; Whiteside, GT	1
Chao, YS; Chen, CN; Chen, JS; Chou, CH; Chu, SH; Wu, YH; Yang, MH	1

Trials

1 trial(s) available for celecoxib and alpha-aminopyridine

Article	Year
A randomized, double-blind, positive-controlled, 3-way cross-over human experimental pain study of a TRPV1 antagonist (V116517) in healthy volunteers and comparison with preclinical profile. Pain, 2016, Volume: 157, Issue:9 Topics: Adolescent; Adult; Aminopyridines; Animals; Capsaicin; Celecoxib; Cross-Over Studies; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Double-Blind Method; Female; Healthy Volunteers; Humans; Male; Middle Aged; Pain; Pain Measurement; Pain Threshold; Physical Stimulation; Pressure; Rats; Rats, Sprague-Dawley; TRPV Cation Channels; Ultraviolet Rays; Young Adult	2016

Article

Year

A randomized, double-blind, positive-controlled, 3-way cross-over human experimental pain study of a TRPV1 antagonist (V116517) in healthy volunteers and comparison with preclinical profile.

Pain, 2016, Volume: 157, Issue:9

Topics: Adolescent; Adult; Aminopyridines; Animals; Capsaicin; Celecoxib; Cross-Over Studies; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Double-Blind Method; Female; Healthy Volunteers; Humans; Male; Middle Aged; Pain; Pain Measurement; Pain Threshold; Physical Stimulation; Pressure; Rats; Rats, Sprague-Dawley; TRPV Cation Channels; Ultraviolet Rays; Young Adult

2016

Other Studies

2 other study(ies) available for celecoxib and alpha-aminopyridine

Article	Year
Kv7 potassium channels in airway smooth muscle cells: signal transduction intermediates and pharmacological targets for bronchodilator therapy. American journal of physiology. Lung cellular and molecular physiology, 2012, Jan-01, Volume: 302, Issue:1 Topics: Aminopyridines; Animals; Anthracenes; Bronchoconstriction; Bronchodilator Agents; Calcium Channel Blockers; Carbamates; Celecoxib; Guinea Pigs; Histamine; Humans; KCNQ Potassium Channels; Male; Methacholine Chloride; Myocytes, Smooth Muscle; Patch-Clamp Techniques; Phenylenediamines; Pyrazoles; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sulfonamides; Verapamil	2012
CC-01 (chidamide plus celecoxib) modifies the tumor immune microenvironment and reduces tumor progression combined with immune checkpoint inhibitor. Scientific reports, 2022, 01-20, Volume: 12, Issue:1 Topics: Adenocarcinoma; Aminopyridines; Animals; Antibodies, Monoclonal; Benzamides; Celecoxib; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Drug Therapy, Combination; Immune Checkpoint Inhibitors; Interferon-gamma; Lymphocytes, Tumor-Infiltrating; Mice; Mice, Inbred BALB C; Mice, Nude; Myeloid-Derived Suppressor Cells; Neoplasm Invasiveness; Neoplastic Processes; Programmed Cell Death 1 Receptor; Tumor Microenvironment; Xenograft Model Antitumor Assays	2022

Article

Year

Kv7 potassium channels in airway smooth muscle cells: signal transduction intermediates and pharmacological targets for bronchodilator therapy.

American journal of physiology. Lung cellular and molecular physiology, 2012, Jan-01, Volume: 302, Issue:1

Topics: Aminopyridines; Animals; Anthracenes; Bronchoconstriction; Bronchodilator Agents; Calcium Channel Blockers; Carbamates; Celecoxib; Guinea Pigs; Histamine; Humans; KCNQ Potassium Channels; Male; Methacholine Chloride; Myocytes, Smooth Muscle; Patch-Clamp Techniques; Phenylenediamines; Pyrazoles; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sulfonamides; Verapamil

2012

CC-01 (chidamide plus celecoxib) modifies the tumor immune microenvironment and reduces tumor progression combined with immune checkpoint inhibitor.

Scientific reports, 2022, 01-20, Volume: 12, Issue:1

Topics: Adenocarcinoma; Aminopyridines; Animals; Antibodies, Monoclonal; Benzamides; Celecoxib; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Drug Therapy, Combination; Immune Checkpoint Inhibitors; Interferon-gamma; Lymphocytes, Tumor-Infiltrating; Mice; Mice, Inbred BALB C; Mice, Nude; Myeloid-Derived Suppressor Cells; Neoplasm Invasiveness; Neoplastic Processes; Programmed Cell Death 1 Receptor; Tumor Microenvironment; Xenograft Model Antitumor Assays

2022